Published in Crit Care on March 31, 2008
Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med (2002) 6.37
Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis (1990) 4.99
Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med (1981) 3.85
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med (2006) 3.38
Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax (2003) 2.47
Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med (2002) 2.40
Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol (2003) 1.82
Decreased sodium ion absorption across nasal epithelium of very premature infants with respiratory distress syndrome. J Pediatr (1997) 1.77
Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice. J Physiol (2004) 1.23
KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur Respir J (2004) 1.22
Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis (2006) 1.14
Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome. Crit Care (2008) 1.05
Differential effects of sustained inflation recruitment maneuvers on alveolar epithelial and lung endothelial injury. Crit Care Med (2005) 1.61
Role of nonbronchoscopic lavage for investigating alveolar inflammation and permeability in acute respiratory distress syndrome. Crit Care Med (2006) 1.58
Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.56
miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production. Am J Respir Crit Care Med (2014) 1.45
Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study. Crit Care (2003) 1.39
Influenza-related pneumonia. Clin Med (2012) 1.39
Routine delirium monitoring in a UK critical care unit. Crit Care (2009) 1.31
Retracted Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity (2012) 1.12
Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. J Immunol (2009) 1.07
How outcomes are defined in clinical trials of mechanically ventilated adults and children. Am J Respir Crit Care Med (2014) 1.05
Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med (2009) 0.99
C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood (2011) 0.98
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One (2011) 0.95
Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children. Cochrane Database Syst Rev (2013) 0.94
Pathophysiology of pulmonary hypertension in acute lung injury. Am J Physiol Lung Cell Mol Physiol (2012) 0.92
High-volume haemofiltration for sepsis. Cochrane Database Syst Rev (2013) 0.91
A novel subpopulation of monocyte-like cells in the human lung after lipopolysaccharide inhalation. Eur Respir J (2012) 0.87
Safety and tolerability of nonbronchoscopic lavage in ARDS. Chest (2005) 0.87
Translational research: what does it mean, what has it delivered and what might it deliver? Curr Opin Crit Care (2011) 0.84
Accuracy of LightCycler(R) SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol. BMJ Open (2012) 0.84
Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children. Cochrane Database Syst Rev (2014) 0.83
Clara cell protein CC16. A new lung epithelial biomarker for acute lung injury. Chest (2009) 0.83
RAGE: a biomarker for acute lung injury. Thorax (2008) 0.82
Human models of acute lung injury. Dis Model Mech (2011) 0.80
A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults: research protocol. BMC Infect Dis (2008) 0.80
Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults. J Infect (2010) 0.79
Tea tree oil (5%) body wash versus standard care (Johnson's Baby Softwash) to prevent colonization with methicillin-resistant Staphylococcus aureus in critically ill adults: a randomized controlled trial. J Antimicrob Chemother (2013) 0.78
Novel pulmonary biomarkers in the diagnosis of VAP. Thorax (2010) 0.78
Role responsibilities in mechanical ventilation and weaning in pediatric intensive care units: a national survey. Am J Crit Care (2013) 0.77
Hot off the breath: the 2009 H1N1 flu pandemic may be gone but should not be forgotten. Thorax (2010) 0.77
Stem cells for respiratory failure. Curr Opin Crit Care (2015) 0.76
Keratinocyte growth factor in acute lung injury--a work in progress. Crit Care Med (2009) 0.75
Benefits of statins in the critically ill: promising but not proven. Crit Care Med (2011) 0.75
What is the score with mortality predictions in acute lung injury? Crit Care Med (2008) 0.75
Statin therapy in critical illness: an international survey of intensive care physicians' opinions, attitudes and practice. BMC Clin Pharmacol (2012) 0.75
Phagocyte priming as a prognostic indicator in the intensive care unit. J Trauma (2003) 0.75